AnaptysBio Inc Stock
AnaptysBio Inc Stock
The AnaptysBio Inc stock is trending slightly upwards today, with an increase of €0.20 (0.860%) compared to yesterday's price.
With 9 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 45 € shows a very positive potential of 92.31% compared to the current price of 23.4 € for AnaptysBio Inc.
Pros and Cons of AnaptysBio Inc in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of AnaptysBio Inc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| AnaptysBio Inc | 0.860% | -2.521% | 16.583% | 31.073% | 19.588% | 8.411% | - |
| Immunic Inc. | -1.090% | 0.337% | -3.406% | -26.208% | -16.713% | -88.414% | - |
| NanoViricides Inc. | 32.120% | 7.843% | 55.660% | 58.654% | 74.603% | -38.570% | -61.322% |
| Ocuphire Pharma Inc. | 0.510% | -6.730% | -4.819% | -65.801% | -43.470% | - | - |
Comments
AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $34.00 price target on the stock.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio, Inc. (NASDAQ: ANAB) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $47.00 price target on the stock.
Show more
Ratings data for ANAB provided by MarketBeat
AnaptysBio, Inc. (NASDAQ: ANAB) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $34.00 price target on the stock, up previously from $20.00.
Show more
Ratings data for ANAB provided by MarketBeat
News
Why AnaptysBio Stock Zoomed Nearly 8% Higher This Week
Many stocks were wobbly over the past few trading days, but we can't say that about biotech AnaptysBio (NASDAQ: ANAB). The company's shares closed the week almost 8% higher in price, according to
